… was done. Most common primary tumours were melanoma (n=62) and non-small cell lung cancer (n=51). PD-1 inhibitors (n=208) were the commonest monotherapy,…
Non-small cell lung cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning Non-small cell lung cancer
126 articles · page 11 of 11…. While immune checkpoint inhibitors (ICIs) have revolutionized NSCLC treatment, a significant proportion of patients exhibit primary…
…c setting and 27.3% in second-line or later lines of treatment. Lung cancer (29.6%) and breast cancer (24.4%) were the most frequently stud…
…rogrammed death receptor-1 inhibitor pembrolizumab for treating non-small cell lung cancer (NSCLC). Herein, we report the final efficacy, safety, and long…
… vascular E-selectin expression and CD8+ T-cell infiltration in thoracic malignancies.1 Their mechanistic work in murine models is elegant and their …
…ground Lung adenocarcinoma (LUAD) is the most common subtype of non-small cell lung cancer. Although immune checkpoint inhibitors (ICIs) have brought new …